Vontobel Holding’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$561K Sell
898
-80
-8% -$46.9K ﹤0.01% 1026
2026
Q2
$518K Sell
978
-9
-0.9% -$4.15K ﹤0.01% 1035
2026
Q1
$474K Buy
987
+30
+3% +$15.4K ﹤0.01% 870
2025
Q4
$537K Buy
957
+2
+0.2% +$1.14K ﹤0.01% 964
2025
Q3
$491K Sell
955
-667
-41% -$291K ﹤0.01% 956
2025
Q2
$509K Buy
1,622
+112
+7% +$33.6K ﹤0.01% 891
2025
Q1
$460K Sell
1,510
-578
-28% -$194K ﹤0.01% 808
2024
Q4
$694K Buy
2,088
+664
+47% +$225K ﹤0.01% 694
2024
Q3
$475K Buy
1,424
+824
+137% +$313K ﹤0.01% 796
2024
Q2
$247K Sell
600
-29
-5% -$11.5K ﹤0.01% 941
2024
Q1
$254K Buy
+629
New +$221K ﹤0.01% 947
2022
Q2
– Sell
-2,909
Closed -$476K – 1084
2022
Q1
$476K Sell
2,909
-40
-1% -$6.6K ﹤0.01% 806
2021
Q4
$642K Buy
+2,949
New +$618K 0.01% 759

Other funds holding MEDP

Vontobel Holding's MEDP Position: Q3 2026 in Review

Vontobel Holding reduced its Medpace (MEDP) stake by 8.2% in Q3 2026, selling an estimated $46.9K and leaving 898 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

Vontobel Holding first reported a position in MEDP in Q4 2021 and has held it in 13 quarters since. The position peaked at $694K in Q4 2024. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Vontobel Holding held 898 shares of Medpace worth $561K as of Q3 2026.
  • Vontobel Holding sold 80 Medpace shares in Q3 2026, an estimated $46.9K.
  • Medpace made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1026 holding.
  • Vontobel Holding first reported a position in Medpace in Q4 2021 and has held it in 13 quarters since.
  • Vontobel Holding's Medpace position peaked at $694K in Q4 2024.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.